These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 18520612

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.
    Schwab M, Schäffeler E, Marx C, Fischer C, Lang T, Behrens C, Gregor M, Eichelbaum M, Zanger UM, Kaskas BA.
    Pharmacogenetics; 2002 Aug; 12(6):429-36. PubMed ID: 12172211
    [Abstract] [Full Text] [Related]

  • 23. Impact of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations in patients with chronic inflammatory diseases.
    Schedel J, Gödde A, Schütz E, Bongartz TA, Lang B, Schölmerich J, Müller-Ladner U.
    Ann N Y Acad Sci; 2006 Jun; 1069():477-91. PubMed ID: 16855176
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Bioequivalence of azathioprine products.
    Baker DE.
    Rev Gastroenterol Disord; 2003 Jun; 3(4):219-23. PubMed ID: 14668694
    [Abstract] [Full Text] [Related]

  • 28. Severe azathioprine-induced myelotoxicity in a kidney transplant patient with thiopurine S-methyltransferase-deficient genotype (TPMT*3A/*3C).
    Kurzawski M, Dziewanowski K, Ciechanowski K, Droździk M.
    Transpl Int; 2005 May; 18(5):623-5. PubMed ID: 15819814
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease.
    Ansari A, Hassan C, Duley J, Marinaki A, Shobowale-Bakre EM, Seed P, Meenan J, Yim A, Sanderson J.
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1743-50. PubMed ID: 12269967
    [Abstract] [Full Text] [Related]

  • 34. Reference intervals for thiopurine S-methyltransferase activity in red blood cells using 6-thioguanine as substrate and rapid non-extraction liquid chromatography.
    Ford LT, Cooper SC, Lewis MJ, Berg JD.
    Ann Clin Biochem; 2004 Jul; 41(Pt 4):303-8. PubMed ID: 15298742
    [Abstract] [Full Text] [Related]

  • 35. Myelotoxicity and hepatotoxicity during azathioprine therapy.
    de Boer NK, Mulder CJ, van Bodegraven AA.
    Neth J Med; 2005 Dec; 63(11):444-6. PubMed ID: 16397313
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Interference free and simplyfied liquid chromatography-based determination of thiopurine S-methyltransferase activity in erythrocytes.
    Khalil MN, Erb N, Khalil PN, Escherich G, Janka-Schaub GE.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul 05; 821(1):105-11. PubMed ID: 15897017
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.